Boehringer Ingelheim produces its own green energy

Boehringer Ingelheim inaugurated a biomass power plant at its Ingelheim site on Monday. With the new power plant, Boehringer Ingelheim is optimizing its energy supply and protecting the environment at the same time: Around 50,000 tons of CO₂ are saved per year. The CO₂ emissions of the site's own energy generation are reduced by 70%. In total, the company is investing EUR 205 million in sustainable infrastructure projects in Ingelheim and will be able to cover 95% of its energy requirements at the site from renewable sources in the future.

The Vice Chairman of the Board of Managing Directors, Michael Schmelmer, described the commissioning as a "significant milestone" for Boehringer Ingelheim and explained: "Part of our sustainability goals is to protect natural resources so that our earth remains a place worth living in for people and animals. With an environmentally friendly and more independent energy supply, we are ensuring stable production in order to be able to deliver medications for patients worldwide."

The ceremonial inauguration was attended by the German Vice Chancellor and Federal Minister of Economics Robert Habeck and Rhineland-Palatinate Environment Minister Katrin Eder. 

Federal Minister for Economic Affairs and Climate Action Robert Habeck said: "The decarbonization of all areas of our economy is necessary in order to achieve global climate targets on the one hand and a reduction in energy imports on the other. Boehringer Ingelheim is a good example of this. The company uses renewable energies for production. It trains and attracts talents as an attractive employer. Last but not least, it invests heavily in research and development, thus contributing to better healthcare and future proofing of the site."

Biomass is an important source of renewable energy and is considered almost CO₂ neutral. The waste wood used as fuel in Ingelheim is a waste product. It comes from the Rhine-Main area and is controlled according to strict quality standards. 

Further measures for CO₂ neutrality by 2030

The company has set itself the goal of making its business operations CO₂ neutral by 2030. To this end, many individual projects are being implemented to save energy worldwide. By constructing more energy-efficient buildings, for example, the company has so far been able to save around 25% percent of its energy needs per square meter of floor space in Ingelheim. In Ingelheim, the company has also been operating its own solar park since 2023. Several other Boehringer Ingelheim sites are already certified as carbon neutral, for example in Dortmund (Germany), Gainesville (USA), Zhangjian (China) or Sant Cugat (Spain).

Boehringer Ingelheim is a biopharmaceutical company active in both human and animal health. As one of the industry’s top investors in Research and Development, the company focuses on developing innovative therapies in areas of high unmet medical need. Independent since its foundation in 1885, Boehringer takes a long-term perspective, embedding sustainability along the entire value chain. More than 53,500 employees serve over 130 markets to build a healthier, more sustainable, and equitable tomorrow. Learn more at www.boehringer-ingelheim.com.